ARTICLE | Clinical News
KBPA101 regulatory update
October 9, 2006 7:00 AM UTC
FDA granted Orphan Drug designation for KBPA101 to treat pneumonia caused by Pseudomonas aeruginosa serotype O11. The human monoclonal antibody against P. aeruginosa also has Orphan Drug designation i...